Pharmafile Logo

NEW Pharma-exclusive Webinar: From Fragmented to Flawless, A Blueprint for Unified Omnichannel in Pharma

Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the blueprint for a truly unified and impactful omnichannel presence. We’ll show you how to eliminate silos and turn fragmented data into actionable insights. Register today to unlock your omnichannel potential!

- PMLiVE

About the webinar

Tired of a fragmented omnichannel strategy that falls short of its promise? Join Impetus Digital’s complimentary webinar, October 28 & 29, designed for life science professionals ready to achieve a truly harmonized and impactful omnichannel presence. We’ll show you how to move beyond basic touchpoints to deliver seamless, intelligent impact across every interaction.

Register today and get the blueprint for a unified strategy that eliminates silos and turns fragmented data into actionable insights. Register today to unlock your omnichannel potential. Among other topics, we’ll cover how to:

  • Orchestrate Your Strategy: Build a cohesive, integrated approach that connects every piece of the puzzle for a more meaningful HCP journey.
  • Generate Actionable Insights: Transform fragmented data into sharp strategic intelligence to inform decision-making across use cases like advisory boards and product launches.
  • Streamline Operations: Eliminate operational complexities and drive unparalleled efficiency with a unified platform and White-Gloveâ„¢ services.
  • Empower Key Initiatives: Discover how a harmonized omnichannel approach can enhance everything from personalized learning paths and patient journey support to agile MSL enablement and product launch readiness.

Plus, discover how AI complements your virtual collaboration efforts!

Click here to sign up

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...